MicroPort® Endovastec™ Hector® Multi-Branch Thoracic Stent Graft

About MicroPort

MicroPort is a mission-driven global medical device company with the goal of providing trustworthy, universal access to state-of-the-art solutions that prolong and reshape lives. Founded in 1998, it has grown into a diversified powerhouse with eight core business units, achieving significant regulatory milestones and commercial successes, including over 10 million coronary stent systems shipped and over 100 installations of its Toumai® surgical robot. Its strategy is built on a federated model of focused subsidiaries, a global R&D and manufacturing footprint, and a proprietary industrial ecosystem designed to foster innovation and streamline market access.

Therapeutic Areas